Mammalian cell cultivation plays a great role in producing protein therapeutics in the last decades. Many engineering parameters are considered for optimization during process development in mammalian cell cultivation, only shear and mixing are especially highlighted in this paper. It is believed that shear stress due to agitation has been over-estimated to damage cells, but shear may result in nonlethal physiological responses. There is no cell damage in the regions where bubbles form, break up and coalescence, but shear stress becomes significant in the wake of rising bubbles and causes great damage to cells in bubble burst regions. Mixing is not sufficient to provide homogeneous dissolved oxygen tension, pH, CO2 and nutrients in large-sc...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...
Industry trends in regenerative medicine highlight a critical need for closed, single use cell cultu...
Schmitz J, Hertel O, Yermakov B, Noll T, Grünberger A. Growth and eGFP-production of CHO-K1 suspensi...
Two dimensional (2-D) cell culture technologies have proven inadequate for large scale manufacturing...
Nowadays, the culture of animal cells has become an inescapable step to produce proteinic compounds....
The scale-up and manufacture of therapies based on intact whole cells presents a major challenge for...
Schmitz J, Täuber S, Westerwalbesloh C, von Lieres E, Noll T, Grünberger A. Development and applicat...
Abstract Biopharmaceutical production processes often use mammalian cells in bioreactors larger than...
Development of a scalable and robust manufacturing process will be critical for successful commercia...
With recent advances in biotechnology, there is a strong and urgent need for robust platforms to cul...
It is envisaged that in order to achieve the stringent quality requirements of future human cell and...
Expanding cell populations extracted from patients or animals is essential to the process of tissue ...
During a cell culture in a bioreactor, the cells are exposed to the shear stress generated by the cu...
In bioproduction processes, cellular heterogeneity can cause unpredictable process outcomes or even ...
<p>Biopharmaceuticals are increasingly produced by modern biotechnological techniques. The in-...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...
Industry trends in regenerative medicine highlight a critical need for closed, single use cell cultu...
Schmitz J, Hertel O, Yermakov B, Noll T, Grünberger A. Growth and eGFP-production of CHO-K1 suspensi...
Two dimensional (2-D) cell culture technologies have proven inadequate for large scale manufacturing...
Nowadays, the culture of animal cells has become an inescapable step to produce proteinic compounds....
The scale-up and manufacture of therapies based on intact whole cells presents a major challenge for...
Schmitz J, Täuber S, Westerwalbesloh C, von Lieres E, Noll T, Grünberger A. Development and applicat...
Abstract Biopharmaceutical production processes often use mammalian cells in bioreactors larger than...
Development of a scalable and robust manufacturing process will be critical for successful commercia...
With recent advances in biotechnology, there is a strong and urgent need for robust platforms to cul...
It is envisaged that in order to achieve the stringent quality requirements of future human cell and...
Expanding cell populations extracted from patients or animals is essential to the process of tissue ...
During a cell culture in a bioreactor, the cells are exposed to the shear stress generated by the cu...
In bioproduction processes, cellular heterogeneity can cause unpredictable process outcomes or even ...
<p>Biopharmaceuticals are increasingly produced by modern biotechnological techniques. The in-...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...
Industry trends in regenerative medicine highlight a critical need for closed, single use cell cultu...
Schmitz J, Hertel O, Yermakov B, Noll T, Grünberger A. Growth and eGFP-production of CHO-K1 suspensi...